Healthcare

Acrux Limited (ASX:ACR) is a Melbourne-based specialty pharmaceutical company focused on developing topical and transdermal medicines. The company combines a commercial genericsBusinesswith research programmes targeting additional healthcare opportunities, including a female testosterone product. This article reviews Acrux’s operating model, development activities and the factors …

Osteopore Limited (ASX:OSX) is a medical technology company developing 3D-printed bioresorbable implants that support bone regeneration. The company’s technology is designed to provide temporary scaffolds that allow natural bone growth before gradually being absorbed by the body. This article examines Osteopore’s technology platform, commercial …

Epsilon Healthcare Limited (ASX:EPN) is an Australian healthcare company focused on pharmaceutical manufacturing, clinical services and medicinal cannabis-related activities. Through its manufacturing subsidiary, Epsilon Pharma, the company is seeking to utilise its pharmaceutical-grade production capabilities to support third-party brands and expand into international markets. …

Peak Processing Limited (ASX:PKP) is a cannabis beverage manufacturing company focused on producing THC-infused drinks for regulated markets. Formerly known as Althea Group Holdings, the company has repositioned its operations towards contract manufacturing, particularly within North America. This article examines how Peak’s manufacturing model …

Atomo Diagnostics Limited (ASX:AT1) is an Australian medical device company focused on simplifying rapid diagnostic testing. The company develops integrated testing devices designed to make sample collection and result interpretation easier for users. This article examines how HIV self-testing and platform partnerships are shaping …

Cleo Diagnostics Ltd (ASX:COV) is a Melbourne-based medical diagnostics company developing tests aimed at improving cancer detection. The company’s current focus is advancing its ovarian cancer blood test through clinical validation and regulatory steps, with evidence generation remaining central to the pathway towards potential …

Cambium Bio Limited (ASX:CMB) is a Sydney-based regenerative medicine company developing biological therapies. The company is advancing Elate Ocular, an investigational treatment for dry eye disease, with its current focus centred on progressing through clinical development and regulatory requirements.